Introduction The ESPEN guideline presents a multidisciplinary focus on clinical nutrition in
inflammatory bowel disease (IBD). Methodology The guideline is based on extensive …

Incidence of IBD is rising in parallel with overweight and obesity. Contrary to conventional
belief, about 15–40% of patients with IBD are obese, which might contribute to the …

The present guideline is the first of a new series of “practical guidelines” based on more
detailed scientific guidelines produced by ESPEN during the last few years. The guidelines …

Inflammatory bowel diseases (IBDs) are chronic problems of gastrointestinal tract (GIT) with
poorly understood aetiology. Patients with any of the two common entities, Crohn's disease …

In the last decades, autoimmune diseases have experienced a dramatic increase in Western
countries. The involvement of environmental factors is strongly suspected to explain this rise …

Prolonged high fat diets (HFD) induce low-grade chronic intestinal inflammation in mice, and
diets high in saturated fat are a risk factor for the development of human inflammatory bowel …

Obesity is prevalent within the inflammatory bowel disease (IBD) population, particularly in
newly developed countries. Several epidemiological studies have suggested that 15%-40 …

This review explores our current understanding of the complex interaction between
environmental risk factors, genetic traits and the development of inflammatory bowel …

Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Background Both obesity and inflammatory bowel disease (IBD) are highly prevalent in
Western societies. IBD, including Crohn's disease (CD) and ulcerative colitis (UC), has been …